U.S. Biotech Stock News

STAAR Surgical (STAA) has quietly turned into a contrarian idea, with the stock down over the past month and past 3 months even as revenue and net income growth look surprisingly strong on paper. See our latest analysis for STAAR Surgical. Zooming out, the recent pullback sits awkwardly against a modestly positive year to date 4.32 percent share price return and a slightly positive 1 year total shareholder return of 1.29 percent. However, the 3 year total shareholder return of negative 48.05...

Preformed Line Products’ Board of Directors recently approved a 5% increase in the quarterly cash dividend, raising it from US$0.20 to US$0.21 per share, payable on January 20, 2026 to shareholders of record as of January 5, 2026. This dividend increase highlights management’s confidence in the company’s financial position and reinforces its ongoing commitment to returning cash to shareholders. We’ll now examine how this higher quarterly dividend payout shapes Preformed Line Products’...

Jefferies’ upgrade of CNO Financial Group (CNO) to a Buy rating, along with a higher expected upside, has put fresh attention on the insurer’s stock and prompted investors to reassess its recent performance. See our latest analysis for CNO Financial Group. That upgrade lands on top of an already solid run, with the share price at $43.55 and a year to date share price return of 17.26%, while the 3 year total shareholder return of 102.62% signals momentum is clearly building. If Jefferies’ call...

Rivian Automotive (RIVN) just turned a lot of heads with its first Autonomy and AI Day, unveiling a homegrown AI driving chip and paid autonomy features that could reshape how investors value the stock. See our latest analysis for Rivian Automotive. The Autonomy and AI Day has clearly fed into that story, with bullish analyst upgrades helping drive Rivian’s roughly 51% 1 month share price return and 62% 1 year total shareholder return. This signals that momentum is building rather than fading...

In recent weeks, Ambarella reported record revenue and raised full-year growth guidance to as much as 38%, yet its shares sold off following the late-November earnings release as investors reacted cautiously. This tension between strong operational momentum and weak short-term sentiment highlights how market perception, rather than fundamentals alone, is currently steering the debate around Ambarella’s outlook. Next, we’ll examine how this disconnect between robust revenue guidance and...

ConnectOne Bancorp (CNOB) is reshuffling a key seat at the risk table, with longtime Chief Risk Officer Michael O’Malley set to depart at year end and veteran risk executive Mark Pappas stepping into the role. See our latest analysis for ConnectOne Bancorp. The reshuffle in ConnectOne’s risk leadership comes as investors have been warming to the story. A 30 day share price return of 12.99 percent has helped extend its year to date share price gain of 22.41 percent and a 1 year total...

Wells Fargo (WFC) has been quietly rewarding patient shareholders, with the stock up about 35% over the past year and roughly 33% year to date, comfortably outpacing the broader market. See our latest analysis for Wells Fargo. The recent leg higher in Wells Fargo’s share price, now around $93.01, reflects investors warming to steadier earnings, improving credit trends, and a cleaner regulatory backdrop. Both short term share price momentum and long term total shareholder returns are firmly...

Darden Restaurants reported past fiscal second-quarter 2026 results showing sales of US$3,102.1 million and net income of US$237.2 million, alongside updated full-year 2026 guidance calling for total sales growth of 8.5% to 9.3% and same-restaurant sales growth of 3.5% to 4.3%. Despite elevated beef costs, Darden delivered same-restaurant sales gains across Olive Garden and LongHorn Steakhouse, leaned on promotions like Never Ending Pasta Bowl, opened more new restaurants than planned, and...

Prosperity Bancshares (PB) has been quietly grinding higher, with the stock up about 5% over the past month and 9% in the past 3 months, even as year-to-date returns remain slightly negative. See our latest analysis for Prosperity Bancshares. That recent 1 month share price return of around 5% sits against a slightly negative year to date share price performance. At the same time, the 5 year total shareholder return of just over 21% suggests momentum is gradually rebuilding rather than...

Earlier this month, Williams-Sonoma’s Board of Directors declared a quarterly cash dividend of US$0.66 per share, payable on February 20, 2026 to shareholders of record as of January 16, 2026. This latest dividend declaration highlights the retailer’s ongoing use of cash returns alongside buybacks to reward shareholders while it continues investing in its business. We’ll now explore how this renewed dividend commitment fits into Williams-Sonoma’s broader investment narrative built around...

WhiteFiber’s Enovum Data Centers subsidiary previously signed a 10-year colocation agreement with Nscale Global Holdings for 40 megawatts of IT load at the NC-1 AI data center campus in Madison, North Carolina, carrying an estimated US$865 million in contracted revenue. The deal makes Nscale the anchor tenant at NC-1, giving WhiteFiber clearer long-term revenue visibility and support for potential campus expansion tailored to advanced AI workloads. Next, we’ll explore how anchoring NC-1 with...

Intel (INTC) has quietly put together a solid run, with the stock up roughly 7% over the past month and almost 90% over the past year, outpacing much of the semiconductor space. See our latest analysis for Intel. At a share price of $36.82, Intel’s 30 day share price return of 6.7% and sharply stronger 1 year total shareholder return of 88.6% suggest momentum is still building as investors reassess its turnaround and foundry ambitions. If you are watching Intel’s revival and wondering what...

SFL (NYSE:SFL) just reshuffled a key slice of its tanker fleet, selling two 2015-built Suezmax vessels and ending charters on two newer ships to free up cash for younger, more efficient tonnage. See our latest analysis for SFL. The move comes after a choppy year for SFL, with a 1 year to date share price return of negative 25.41 percent and a softer 1 year total shareholder return of negative 10.62 percent. The 5 year total shareholder return of 99.50 percent still points to solid long term...

PennyMac Financial Services (PFSI) just caught a tailwind, with shares climbing after a fresh Buy call from Jefferies and a more optimistic stance from Keefe, Bruyette and Woods, both leaning into its earnings momentum. See our latest analysis for PennyMac Financial Services. That bullish call is landing on an already strong tape, with the share price at $134.62 after a 34.84% year to date share price return and a hefty 145.34% three year total shareholder return. This shows that momentum is...

In November 2025, Copa Holdings reported a 10% year-over-year increase in available seat miles to 2,777.6 million and a 10.2% rise in revenue passenger miles to 2,394.7 million, lifting its system load factor slightly to 86.2%. This combination of capacity growth and steady high load factors highlights how Copa is filling additional seats without diluting demand, reinforcing confidence in its regional network strength. Next, we’ll examine how November’s 10% capacity increase and firm 86.2%...

MiMedx Group (MDXG) just added fresh peer reviewed backing for its placental allograft products, with a new Journal of Inflammation study underscoring their immunomodulatory role in complex wound healing and longer term competitive positioning. See our latest analysis for MiMedx Group. Even with this new clinical validation, MiMedx Group’s $7.05 share price sits well below its highs, with a year-to-date share price return of negative 24.03 percent and a powerful three-year total shareholder...

On December 12, 2025, Tyson Foods entered a new Loan Agreement with CoBank, replacing its prior term loan with a senior unsecured revolving credit facility of up to $750 million that matures in three years and includes options to convert borrowings into longer-term tranches. This shift from a fixed term loan to a flexible revolving structure, with the ability to term out debt later, gives Tyson Foods more control over liquidity management, funding costs, and timing of capital needs. We’ll...

In recent days, several major banks including JPMorgan, Barclays, and Keefe, Bruyette & Woods reaffirmed positive analyst ratings on Webster Financial, while Seaport Global reiterated a more cautious Hold stance. This cluster of bullish opinions alongside insider share sales highlights a tension between external optimism about Webster’s prospects and internal portfolio decisions by company executives. We’ll now examine how this wave of upbeat analyst sentiment, especially around regional...

Corcept Therapeutics (CORT) has quietly turned into a strong performer this year, with the stock up about 68% year to date and roughly 63% over the past year, far outpacing the broader market. See our latest analysis for Corcept Therapeutics. The recent 1 month share price return of 8.37% and the latest close at $83.76 suggest investors are steadily repricing Corcept as growth expectations and perceived pipeline risks shift, building on a powerful multi year total shareholder return. If...

Zebra Technologies (ZBRA) has had a choppy run lately, with the stock sliding over the past 3 months even as revenue and net income keep growing. This sets up an interesting valuation debate. See our latest analysis for Zebra Technologies. Zooming out, the stock’s recent 7 day and 90 day share price declines sit against a much steeper year to date slide. At the same time, the 3 year total shareholder return is only slightly positive, suggesting momentum has been fading even as fundamentals...

Balchem (BCPC) just rolled out a 10.3% dividend increase alongside a fresh buyback authorization for up to 4 million shares, a one two signal that management is leaning into shareholder returns. See our latest analysis for Balchem. Those moves land after a fairly muted stretch for the stock, with the share price down modestly year to date even as the five year total shareholder return of 40% shows longer term compounding still at work. If this kind of shareholder friendly story appeals to...

In recent months, analysts at Wells Fargo, Citi, Mizuho, UBS, and others have updated their views on RPM International, with most maintaining positive ratings even as some grew more cautious and insiders increased share sales. This combination of broadly supportive analyst sentiment and rising insider selling offers investors a contrasting read on how external and internal stakeholders view RPM’s prospects. We’ll now explore how this mix of largely positive analyst opinions and heightened...

Piper Sandler analyst Matthew Clark recently maintained a Sell rating on Cathay General Bancorp, as corporate insiders including Vice Chairman Anthony Tang have been increasing share sales amid ongoing operational headwinds. Behind these developments, Cathay General Bancorp has faced a 1.7% decline in annual sales and a 7.5% annual drop in earnings per share over the past two years, pointing to persistent profitability challenges. With analysts turning more cautious and insiders increasing...

KB Home (KBH) just delivered one of those mixed quarters that gets everyone talking, beating expectations on earnings and revenue while simultaneously dialing back its outlook as affordability pressures and a thinner backlog cloud 2026. See our latest analysis for KB Home. The market has quickly repriced that cautious 2026 guidance, with an 8.5% one day share price decline and double digit year to date share price retreat. However, three year total shareholder return remains very strong and...